{"0": ["last", "year", "us", "giant", "pfizer", "world's", "largest", "drug", "company", "pharmaceutical", "revenue", "made", "eye-watering", "profit", "margin", "one", "industry", "veteran", "understandably", "says", "able", "justify", "kinds", "margins", "..", "uk", "example", "widespread", "anger", "industry", "regulator", "predicted", "energy", "companies", "profit", "margins", "would", "grow", "year", "last", "year", "five", "pharmaceutical", "companies", "made", "profit", "margin", "more-pfizer", "hoffmann-la", "roche", "abbvie", "glaxosmithkline", "gsk", "eli", "lilly"], "1": ["valerie", "paris", "oecd", "february", "12:15", "pm", "edt", "photo", "flickr", "user", "images_of_money", "united", "states", "spends", "almost", "1,000", "per", "person", "per", "year", "pharmaceuticals", "around", "percent", "next", "highest", "spender", "canada", "twice", "much", "countries", "like", "france", "germany", "spend", "part", "u", "always", "attractive", "market", "pharmaceutical", "companies", "big", "accounting", "percent", "world", "market", "low", "levels", "price", "regulation", "offers", "barriers", "market", "entry", "fda", "approval", "secured"], "2": ["extrapolated", "global", "market", "pharmaceutical", "revenue", "loss", "estimated", "billion", "annually", "billion", "actual", "total", "global", "revenue", "1,520", "billion", "potential", "total", "global", "revenue", "pharmaceutical", "revenue", "side", "however", "impact", "medication", "non-adherence", "yet", "accurately", "quanti\ufb01", "ed", "market", "assumption", "relied", "upon", "date", "quoted", "extensively", "billion", "globally", "8,10", "felt", "gross", "underestimate", "\u2014", "prompting", "project"], "3": ["teradata", "magazine", "predicted", "billion", "u", "sales", "could", "lost", "top", "pharmaceutical", "companies", "result", "slowdown", "r", "innovation", "expiry", "patents", "major", "products", "blockbuster", "drugs", "losing", "patent", "top", "three", "best-selling", "drugs", "united", "states", "abilify", "6.3", "billion", "nexium", "billion", "humira", "5.4", "billion", "best-selling", "drug", "ever", "lipitor", "averaged", "billion", "annually", "netted", "billion", "total", "lifetime", "pfizer's", "patent", "expired", "november"], "4": ["total", "value", "u", "consumption", "pharmaceutical", "drugs", "billion", "percent", "worldwide", "market", "share", "reflected", "percent", "increase", "since", "total", "value", "shipments", "domestic", "producers", "billion", "billion", "estimated", "exports"], "5": ["first", "time", "ever", "global", "spending", "prescription", "drugs", "topped", "billion", "even", "growth", "slowed", "somewhat", "europe", "north", "america", "united", "states", "accounts", "third", "global", "pharmaceutical", "market", "billion", "annual", "sales", "followed", "eu", "japan", "pdf", "emerging", "markets", "china", "russia", "south", "korea", "mexico", "outpaced", "market", "growing", "huge", "percent", "top", "three", "best-selling", "drugs", "united", "states", "abilify", "6.3", "billion", "nexium", "billion", "humira", "5.4", "billion", "best-selling", "drug", "ever", "lipitor", "averaged", "billion", "annually", "netted", "billion", "total", "lifetime", "pfizer's", "patent", "expired", "november"], "6": ["\u2022", "global", "generic", "medicines", "market", "worth", "us", "billion", "total", "sales", "much", "larger", "commonly", "reported", "market", "unbranded", "generics", "alone", "\u2022", "patterns", "medicines", "consumption", "differ", "high-and", "low-income", "countries", "market", "share", "usa", "alone", "rose", "18.4", "world", "total", "\u2022", "low-income", "countries", "share", "pharmaceuticals", "consumed", "fell", "3.9", "total", "2.9", "share", "sales", "fell", "0.98", "0.64"], "7": ["implications", "estimate", "billion", "pharmaceutical", "revenue", "lost", "annually", "us", "alone", "billion", "globally", "due", "medication", "non-adherence", "accurate", "estimate", "date", "points", "far", "signi\ufb01", "cant", "problem", "previously", "believed", "acknowledged", "pharmaceutical", "revenue", "side", "however", "impact", "medication", "non-adherence", "yet", "accurately", "quanti\ufb01", "ed", "market", "assumption", "relied", "upon", "date", "quoted", "extensively", "billion", "globally", "8,10", "felt", "gross", "underestimate", "\u2014", "prompting", "project"], "8": ["total", "level", "pharmaceutical", "revenue", "worldwide", "reached", "nearly", "one", "trillion", "u", "dollars", "north", "america", "responsible", "largest", "portion", "generating", "percent", "revenues", "mostly", "due", "leading", "role", "u", "pharmaceutical", "industry", "based", "prescription", "sales", "nyc-based", "pfizer", "world", "second", "largest", "pharmaceutical", "company", "company", "generated", "billion", "u", "dollars", "pure", "pharmaceutical", "sales", "total", "revenue", "stood", "nearly", "billion", "u", "dollars", "top", "global", "players", "united", "states", "johnson", "johnson", "merck", "abbvie"]}